SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (263)2/21/2003 10:57:18 PM
From: keokalani'nui  Read Replies (1) | Respond to of 824
 
>>they were over 2/3rd through enrollment of 3,000 patient primo-cabg phase III<<

I heard the same, but was corrected---they said that in in November at AHA they announced they were 2/3 way through.